Geographic distribution of malignant mesothelioma incidence and survival in Australia.


Journal

Lung cancer (Amsterdam, Netherlands)
ISSN: 1872-8332
Titre abrégé: Lung Cancer
Pays: Ireland
ID NLM: 8800805

Informations de publication

Date de publication:
05 2022
Historique:
received: 13 01 2022
revised: 14 03 2022
accepted: 22 03 2022
pubmed: 5 4 2022
medline: 4 5 2022
entrez: 4 4 2022
Statut: ppublish

Résumé

To understand the geographic distribution of and area-level factors associated with malignant mesothelioma incidence and survival in Australia. Generalised linear models and Bayesian spatial models were fitted using population registry data. Area-level covariates were socioeconomic quintile, remoteness category and state or territory. The maximised excess events test was used to test for spatial heterogeneity. There was strong evidence of spatial differences in standardised incidence rates for malignant mesothelioma but survival was uniformly poor. Incidence rates varied by state or territory and were lower in remote areas. Patterns in the geographic distribution of modelled incidence counts for malignant mesothelioma differed substantially from patterns of standardised incidence rates. Geographic variation in the modelled incidence counts of malignant mesothelioma demonstrates varying demand for diagnostic and management services. The long latency period for this cancer coupled with migration complicates any associations with patterns of exposure, however some of the geographic distribution of diagnoses can be explained by the location of historical mines and asbestos-related industries.

Identifiants

pubmed: 35378379
pii: S0169-5002(22)00386-5
doi: 10.1016/j.lungcan.2022.03.017
pii:
doi:

Substances chimiques

Asbestos 1332-21-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

17-24

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Jessica K Cameron (JK)

Viertel Cancer Research Centre, Cancer Council Queensland, 553 Gregory Terrace, Fortitude Valley, QLD 4006, Australia; School of Mathematical Sciences, Faculty of Science, Queensland University of Technology, 2 George St, Brisbane, QLD 4000, Australia. Electronic address: jessicacameron@cancerqld.org.au.

Joanne Aitken (J)

Viertel Cancer Research Centre, Cancer Council Queensland, 553 Gregory Terrace, Fortitude Valley, QLD 4006, Australia; School of Public Health, Faculty of Medicine, The University of Queensland, 266 Herston Rd, Herston, QLD 4006, Australia; School of Public Health and Social Work, Faculty of Health, Queensland University of Technology, Victoria Park Rd, Kelvin Grove, QLD 4059, Australia; Institute for Resilient Regions, University of Southern Queensland, 37 Sinnathamby Blvd, Springfield Central, QLD 4300, Australia.

Alison Reid (A)

Curtin School of Population Health, Faculty of Health Sciences, Curtin University, Kent St, Bentley, WA 6102, Australia.

Kerrie Mengersen (K)

School of Mathematical Sciences, Faculty of Science, Queensland University of Technology, 2 George St, Brisbane, QLD 4000, Australia; Centre for Data Science, Queensland University of Technology, 2 George St, Brisbane, QLD 4000, Australia.

Susanna Cramb (S)

Australian Centre for Health Services Innovation (AusHSI) and Centre for Healthcare Transformation, Faculty of Health, Queensland University of Technology (QUT), 60 Musk Ave, Kelvin Grove, QLD 4059, Australia; Jamieson Trauma Institute, Royal Brisbane and Women's Hospital, Herston, QLD 4029, Australia; Centre for Data Science, Queensland University of Technology, 2 George St, Brisbane, QLD 4000, Australia.

Paige Preston (P)

School of Public Health, Faculty of Medicine, The University of Queensland, 266 Herston Rd, Herston, QLD 4006, Australia; Advocacy, Cancer Council Queensland, 553 Gregory Terrace, Fortitude Valley, QLD 4006, Australia.

Bruce Armstrong (B)

School of Public Health, Faculty of Medicine and Health, Fisher Road, The University of Sydney, NSW 2006, Australia; School of Global and Population Health, The University of Western Australia, 35 Stirling Hwy, Perth, WA 6009, Australia.

Peter Baade (P)

Viertel Cancer Research Centre, Cancer Council Queensland, 553 Gregory Terrace, Fortitude Valley, QLD 4006, Australia; School of Mathematical Sciences, Faculty of Science, Queensland University of Technology, 2 George St, Brisbane, QLD 4000, Australia; Menzies Health Institute Queensland, Griffith Health Centre, Griffith University, Southport, QLD 4222, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH